GNS - Ticker AI Digest

Genus PLC 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (GNS) 1
GNS 06:01
Genus PLC
Half Year Trading Update – Ahead of expectations
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Genus plc, a global leader in animal genetics, released a half-year trading update for the six months ended 31 December 2025 (H1 FY26), reporting strong performance ahead of expectations. The company expects to report a first-half adjusted profit before tax of approximately £50 million (excluding a £5.6 million milestone payment from BCA) and £55.6 million including the payment. This performance was driven by strong trading in its PIC (pig) and ABS (dairy and beef cattle) businesses.
The Board now anticipates full-year FY26 adjusted profit before tax to exceed the top-end of current market expectations (£85.0 million). Genus also confirmed regulatory approval from Chinas SASAC for its accelerated porcine joint venture, triggering the final $7.5 million (£5.6 million) milestone payment from BCA, expected in the fiscal third quarter.
Genus will announce its interim results on 26 February 2026. The company continues to leverage its proprietary breeding lines, biotechnology, and global network to drive innovation, including the development of the PRRS Resistant Pig, pending regulatory approvals.
**Key Highlights**
H1 FY26 adjusted profit before tax£50m (excl. BCA payment) / £55.6m (incl. BCA payment).
Full-year FY26 profit expected to exceed market consensus of £85.0m.
Chinese porcine joint venture approved, with £5.6m milestone payment expected in Q3 FY26.
Continued strong performance in PIC and ABS businesses.
Interim results to be announced on 26 February 2026.
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 1
GNS 06:01
Genus PLC
Half Year Trading Update – Ahead of expectations
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Genus plc, a global leader in animal genetics, released a half-year trading update for the six months ended 31 December 2025 (H1 FY26), reporting strong performance ahead of expectations. The company expects to report a first-half adjusted profit before tax of approximately £50 million (excluding a £5.6 million milestone payment from BCA) and £55.6 million including the payment. This performance was driven by strong trading in its PIC (pig) and ABS (dairy and beef cattle) businesses.
The Board now anticipates full-year FY26 adjusted profit before tax to exceed the top-end of current market expectations (£85.0 million). Genus also confirmed regulatory approval from Chinas SASAC for its accelerated porcine joint venture, triggering the final $7.5 million (£5.6 million) milestone payment from BCA, expected in the fiscal third quarter.
Genus will announce its interim results on 26 February 2026. The company continues to leverage its proprietary breeding lines, biotechnology, and global network to drive innovation, including the development of the PRRS Resistant Pig, pending regulatory approvals.
**Key Highlights**
H1 FY26 adjusted profit before tax£50m (excl. BCA payment) / £55.6m (incl. BCA payment).
Full-year FY26 profit expected to exceed market consensus of £85.0m.
Chinese porcine joint venture approved, with £5.6m milestone payment expected in Q3 FY26.
Continued strong performance in PIC and ABS businesses.
Interim results to be announced on 26 February 2026.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 1
GNS 06:01
Genus PLC
Half Year Trading Update – Ahead of expectations
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Genus plc, a global leader in animal genetics, released a half-year trading update for the six months ended 31 December 2025 (H1 FY26), reporting strong performance ahead of expectations. The company expects to report a first-half adjusted profit before tax of approximately £50 million (excluding a £5.6 million milestone payment from BCA) and £55.6 million including the payment. This performance was driven by strong trading in its PIC (pig) and ABS (dairy and beef cattle) businesses.
The Board now anticipates full-year FY26 adjusted profit before tax to exceed the top-end of current market expectations (£85.0 million). Genus also confirmed regulatory approval from Chinas SASAC for its accelerated porcine joint venture, triggering the final $7.5 million (£5.6 million) milestone payment from BCA, expected in the fiscal third quarter.
Genus will announce its interim results on 26 February 2026. The company continues to leverage its proprietary breeding lines, biotechnology, and global network to drive innovation, including the development of the PRRS Resistant Pig, pending regulatory approvals.
**Key Highlights**
H1 FY26 adjusted profit before tax£50m (excl. BCA payment) / £55.6m (incl. BCA payment).
Full-year FY26 profit expected to exceed market consensus of £85.0m.
Chinese porcine joint venture approved, with £5.6m milestone payment expected in Q3 FY26.
Continued strong performance in PIC and ABS businesses.
Interim results to be announced on 26 February 2026.

AI Crunch

Single-Ticker AI Crunch
GNS signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Genus PLC. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full GNS AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for GNS on 2026-01-16.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
1785187584
Enterprise Value
2301626724
Public Float
97.98
Broker Target
3163.3
Shares Out
66413228
Long Interest
50
Short Interest
50
Exchange
LSE
Currency Code
GBX
ISIN
GB0002074580
Market
LSE - MAIN MARKET
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
0.33
Ex Divi
2026-03-05
Earnings Date
2026-02-26
Net Debt
217900000.0
Cash
48000000.0
EPS
0.71
Net Income
19300000.0
Revenue
672800000.0
Enterprise Value
2301626724
Trailing PE
37.8592
Forward PE
25.5102
Price Sales TTM
2.6565
Price Book MRQ
3.3655
EV Revenue
2.8475
EV EBITDA
15.0196

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
28.7538
Institutions As Of
2026-03-10
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
6
Sale Director Dealing
6
Purchase TR1
6
Sale TR1
4
Broker Coverage Rows
0
Institution Holders Tracked
6
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit GNS.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2026-01-16 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
Genus PLC has fresh news flow feeding the chart narrative.
AI Charts Studio
GNS Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-01-16 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast -2.55%
RSI Gauge
Price Change
AI Forecast